Figures & data
Scheme 1. The schematic representation of the present investigation established that Rutin-Aucubin loaded Chitosan NPs inducing sustained drug release and apoptosis of cancer cells.
![Scheme 1. The schematic representation of the present investigation established that Rutin-Aucubin loaded Chitosan NPs inducing sustained drug release and apoptosis of cancer cells.](/cms/asset/06208f3f-0a1c-4a37-8721-4225f702cf11/ymte_a_2327157_sch0001_oc.jpg)
Figure 1. Characterization of nanocomposites (a) TEM image of chitosan rutin-aucubin (b) size distribution spectrum of chitosan rutin-aucubin (c) Zeta potential of chitosan rutin-aucubin.
![Figure 1. Characterization of nanocomposites (a) TEM image of chitosan rutin-aucubin (b) size distribution spectrum of chitosan rutin-aucubin (c) Zeta potential of chitosan rutin-aucubin.](/cms/asset/b507e012-3506-487a-9faf-8b25d7cd302c/ymte_a_2327157_f0001_oc.jpg)
Figure 3. Cytocompatibility of chitosan, chitosan-rutin, chitosan rutin-aucubin in L929 cells at different incubation hours (0 h, 24 h and 48 h); scale bar = 100 µm.
![Figure 3. Cytocompatibility of chitosan, chitosan-rutin, chitosan rutin-aucubin in L929 cells at different incubation hours (0 h, 24 h and 48 h); scale bar = 100 µm.](/cms/asset/d52c7e57-ce0c-4c8e-b0f5-683f1891582e/ymte_a_2327157_f0003_oc.jpg)
Figure 4. Cell viability MTT study in U87 glioma cells treated with chitosan rutin, chitosan aucubin and chitosan rutin-aucubin at various concentrations for 24, 48 and 72 h. The data are indicative of at least three individual studies and are shown as mean ± sem. ANOVA and Student’s t-test are used; *p < 0.05, **p < 0.01, ***p < 0.001.
![Figure 4. Cell viability MTT study in U87 glioma cells treated with chitosan rutin, chitosan aucubin and chitosan rutin-aucubin at various concentrations for 24, 48 and 72 h. The data are indicative of at least three individual studies and are shown as mean ± sem. ANOVA and Student’s t-test are used; *p < 0.05, **p < 0.01, ***p < 0.001.](/cms/asset/6079f536-dc93-4d41-87a3-64995931e19c/ymte_a_2327157_f0004_oc.jpg)
Figure 5. Cell viability study in U87 glioma cells AO/EB-stained (a) control (b) chitosan (c) chitosan-rutin (d) chitosan-aucubin (e) chitosan rutin-aucubin; scale bar = 100 µm.
![Figure 5. Cell viability study in U87 glioma cells AO/EB-stained (a) control (b) chitosan (c) chitosan-rutin (d) chitosan-aucubin (e) chitosan rutin-aucubin; scale bar = 100 µm.](/cms/asset/c16895a6-118f-457a-a655-01c124dc67e1/ymte_a_2327157_f0005_oc.jpg)
Figure 6. Flow cytometry images of apoptosis study in U87 cells with chitosan rutin, chitosan aucubin and chitosan rutin-aucubin at various concentrations for 48 h.
![Figure 6. Flow cytometry images of apoptosis study in U87 cells with chitosan rutin, chitosan aucubin and chitosan rutin-aucubin at various concentrations for 48 h.](/cms/asset/54e79d6d-bdfd-4821-bdd3-3a1df7fd4e21/ymte_a_2327157_f0006_oc.jpg)
Figure 7. Apoptosis study in U87 cells with chitosan rutin, chitosan aucubin and chitosan rutin-aucubin at various concentrations for 48 h. The data are indicative of at least three individual studies and are shown as mean ± sem. ANOVA and Student’s t-test are used; *p < 0.05, **p < 0.01, ***p < 0.001.
![Figure 7. Apoptosis study in U87 cells with chitosan rutin, chitosan aucubin and chitosan rutin-aucubin at various concentrations for 48 h. The data are indicative of at least three individual studies and are shown as mean ± sem. ANOVA and Student’s t-test are used; *p < 0.05, **p < 0.01, ***p < 0.001.](/cms/asset/0686373c-17bd-4159-8c96-742d5a344024/ymte_a_2327157_f0007_oc.jpg)
Figure 9. In vitro wound scratch assay for chitosan rutin-aucubin at different incubation time (0 h, 6 h, 12 h, 24 h & 48 h); scale bar = 100 µm.
![Figure 9. In vitro wound scratch assay for chitosan rutin-aucubin at different incubation time (0 h, 6 h, 12 h, 24 h & 48 h); scale bar = 100 µm.](/cms/asset/cb9847c0-2ae6-44e0-9f85-4d52e698f0c3/ymte_a_2327157_f0009_oc.jpg)
Data availability statement
The data used to support the findings of this study are available from the corresponding author upon request.